222 related articles for article (PubMed ID: 25266604)
1. Efficacy of hemostatic matrix and microporous polysaccharide hemospheres.
Lewis KM; Atlee H; Mannone A; Lin L; Goppelt A
J Surg Res; 2015 Feb; 193(2):825-30. PubMed ID: 25266604
[TBL] [Abstract][Full Text] [Related]
2. Hemostatic agent microporous polysaccharide hemospheres (MPH) does not affect healing or intact sinus mucosa.
Antisdel JL; Janney CG; Long JP; Sindwani R
Laryngoscope; 2008 Jul; 118(7):1265-9. PubMed ID: 18438268
[TBL] [Abstract][Full Text] [Related]
3. Hemostatic Comparison of a Polysaccharide Powder and a Gelatin Powder.
Singh RK; Baumgartner B; Mantei JR; Parreno RN; Sanders PJ; Lewis KM; Barry JJ
J Invest Surg; 2019 Aug; 32(5):393-401. PubMed ID: 29420097
[No Abstract] [Full Text] [Related]
4. Evaluation of microporous polysaccharide hemospheres as a novel hemostatic agent in open partial nephrectomy: favorable experimental results in the porcine model.
Murat FJ; Ereth MH; Dong Y; Piedra MP; Gettman MT
J Urol; 2004 Sep; 172(3):1119-22. PubMed ID: 15311053
[TBL] [Abstract][Full Text] [Related]
5. Comparative safety and efficacy of topical hemostatic agents in a rat neurosurgical model.
Ereth MH; Schaff M; Ericson EF; Wetjen NM; Nuttall GA; Oliver WC
Neurosurgery; 2008 Oct; 63(4 Suppl 2):369-72; discussion 372. PubMed ID: 18981845
[TBL] [Abstract][Full Text] [Related]
6. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in children undergoing adenoidectomy.
Mathiasen RA; Cruz RM
Otolaryngol Head Neck Surg; 2004 Nov; 131(5):601-5. PubMed ID: 15523433
[TBL] [Abstract][Full Text] [Related]
7. Microporous Polysaccharide Hemospheres do not enhance abdominal infection in a rat model compared with gelatin matrix.
Ereth MH; Dong Y; Schrader LM; Henderson NA; Agarwal S; Oliver WC; Nuttall GA
Surg Infect (Larchmt); 2009 Jun; 10(3):273-6. PubMed ID: 19485784
[TBL] [Abstract][Full Text] [Related]
8. Various local hemostatic agents with different modes of action; an in vivo comparative randomized vascular surgical experimental study.
Björses K; Holst J
Eur J Vasc Endovasc Surg; 2007 Mar; 33(3):363-70. PubMed ID: 17137801
[TBL] [Abstract][Full Text] [Related]
9. Microporous polysaccharide hemospheres for management of laparoscopic trocar injury to the spleen.
Humphreys MR; Castle EP; Andrews PE; Gettman MT; Ereth MH
Am J Surg; 2008 Jan; 195(1):99-103. PubMed ID: 18070734
[TBL] [Abstract][Full Text] [Related]
10. Comparison of two gelatin and thrombin combination hemostats in a porcine liver abrasion model.
Lewis KM; Atlee HD; Mannone AJ; Dwyer J; Lin L; Goppelt A; Redl H
J Invest Surg; 2013 Jun; 26(3):141-8. PubMed ID: 23514063
[TBL] [Abstract][Full Text] [Related]
11. Damage control management of experimental grade 5 renal injuries: further evaluation of FloSeal gelatin matrix.
Pursifull NF; Morris MS; Harris RA; Morey AF
J Trauma; 2006 Feb; 60(2):346-50. PubMed ID: 16508494
[TBL] [Abstract][Full Text] [Related]
12. Microporous Polysaccharide Hemospheres (MPH) for cerebral hemostasis: a preliminary report.
Galarza M; Porcar OP; Gazzeri R; Martínez-Lage JF
World Neurosurg; 2011; 75(3-4):491-4. PubMed ID: 21600502
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a gelatin matrix as a topical hemostatic agent for hepatic bleeding in the dog.
Polidoro DP; Kass PH
J Am Anim Hosp Assoc; 2013; 49(5):308-17. PubMed ID: 23861265
[TBL] [Abstract][Full Text] [Related]
14. Hemostatic efficacy of a novel, PEG-coated collagen pad in clinically relevant animal models.
Lewis KM; Schiviz A; Hedrich HC; Regenbogen J; Goppelt A
Int J Surg; 2014; 12(9):940-4. PubMed ID: 25106082
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the efficacy of five standard topical hemostats: a study in porcine liver and spleen models of surgical bleeding.
Paternò VA; Bisin A; Addis A
BMC Surg; 2020 Sep; 20(1):215. PubMed ID: 32977788
[TBL] [Abstract][Full Text] [Related]
16. A Comparative Efficacy Evaluation of Recombinant Topical Thrombin (RECOTHROM
Slezak P; Keibl C; Labahn D; Schmidbauer A; Genyk Y; Gulle H
J Invest Surg; 2021 Aug; 34(8):862-868. PubMed ID: 31955627
[TBL] [Abstract][Full Text] [Related]
17. Microporous polysaccharide hemosphere absorbable hemostat use in cardiothoracic surgical procedures.
Bruckner BA; Blau LN; Rodriguez L; Suarez EE; Ngo UQ; Reardon MJ; Loebe M
J Cardiothorac Surg; 2014 Aug; 9():134. PubMed ID: 25085116
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of FloSeal as a potential intracavitary hemostatic agent.
Klemcke HG
J Trauma; 2006 Feb; 60(2):385-9. PubMed ID: 16508500
[TBL] [Abstract][Full Text] [Related]
19. Comparison of a gelatin thrombin versus a modified absorbable polymer as a unique treatment for severe hepatic hemorrhage in swine.
Sánchez Del Valle FJ; De Nicolás L; Fernández G; Fernández P; Gómez E; Aranaz Corral I
Sci Rep; 2023 Nov; 13(1):20854. PubMed ID: 38012204
[TBL] [Abstract][Full Text] [Related]
20. Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery.
Nasso G; Piancone F; Bonifazi R; Romano V; Visicchio G; De Filippo CM; Impiombato B; Fiore F; Bartolomucci F; Alessandrini F; Speziale G
Ann Thorac Surg; 2009 Nov; 88(5):1520-6. PubMed ID: 19853105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
